Cargando…
Plasma levels of phosphorylated tau and neurofilament light chain as potential biomarkers for Alzheimer’s disease: A biochemical analysis in Pakistani population
The National Institute on Aging-Alzheimer's Association's research framework in 2018 proposed a molecular construct for the diagnosis of Alzheimer’s disease (AD). Nonetheless, the clinical exclusionary strategy is still the mainstay of AD diagnosis in Pakistan. We looked at the plasma leve...
Autores principales: | Faraz Ahmed, Tehniat, Bilal Azmi, Muhammad, Imtiaz, Fauzia, Zaman, Uzma, Ahmed, Affan, Shahbaz, Naila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236364/ https://www.ncbi.nlm.nih.gov/pubmed/37273267 http://dx.doi.org/10.1016/j.jsps.2023.05.013 |
Ejemplares similares
-
Transcript-Level
In Silico Analysis of Alzheimer’s
Disease-Related Gene Biomarkers and Their Evaluation with Bioactive
Flavonoids to Explore Therapeutic Interactions
por: Azmi, Muhammad Bilal, et al.
Publicado: (2023) -
Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease
por: Moscoso, Alexis, et al.
Publicado: (2021) -
Neurofilament heavy chain side arm phosphorylation regulates axonal transport of neurofilaments
por: Ackerley, Steven, et al.
Publicado: (2003) -
Serum phosphorylated tau protein 181 and neurofilament light chain in cognitively impaired heart failure patients
por: Traub, Jan, et al.
Publicado: (2022) -
Plasma tau and neurofilament light chain as biomarkers of Alzheimer's disease and their relation to cognitive functions
por: Abed, Sadiruldeen Sami, et al.
Publicado: (2023)